Shantan Reddy

2.3k total citations · 1 hit paper
16 papers, 709 citations indexed

About

Shantan Reddy is a scholar working on Oncology, Cancer Research and Infectious Diseases. According to data from OpenAlex, Shantan Reddy has authored 16 papers receiving a total of 709 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Cancer Research and 4 papers in Infectious Diseases. Recurrent topics in Shantan Reddy's work include Cancer, Hypoxia, and Metabolism (4 papers), Viral gastroenteritis research and epidemiology (3 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). Shantan Reddy is often cited by papers focused on Cancer, Hypoxia, and Metabolism (4 papers), Viral gastroenteritis research and epidemiology (3 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). Shantan Reddy collaborates with scholars based in United States, Russia and Switzerland. Shantan Reddy's co-authors include Frederic D. Bushman, Saar Gill, Christopher L. Nobles, J.K. Everett, Gabriela Plesa, Roddy S. O’Connor, John Leferovich, Feng Shen, Adrian Cantu and Michael C. Milone and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Shantan Reddy

16 papers receiving 689 citations

Hit Papers

Rapid manufacturing of no... 2022 2026 2023 2024 2022 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shantan Reddy United States 12 386 299 146 116 116 16 709
Xiaochuan Shan United States 12 235 0.6× 356 1.2× 143 1.0× 35 0.3× 60 0.5× 20 779
Hossam A. Abdelsamed United States 13 625 1.6× 417 1.4× 106 0.7× 82 0.7× 61 0.5× 30 1.2k
Malika Hale United States 13 400 1.0× 488 1.6× 293 2.0× 47 0.4× 34 0.3× 21 981
Meagan A. Jacoby United States 18 539 1.4× 453 1.5× 49 0.3× 62 0.5× 69 0.6× 65 1.3k
Jason E. Ekert United States 9 143 0.4× 155 0.5× 77 0.5× 114 1.0× 40 0.3× 13 519
Charles H. Pletcher United States 12 244 0.6× 196 0.7× 32 0.2× 73 0.6× 67 0.6× 18 722
Lisa Senzel United States 11 258 0.7× 294 1.0× 115 0.8× 49 0.4× 17 0.1× 31 822
Jorge Schettini United States 13 228 0.6× 299 1.0× 95 0.7× 21 0.2× 66 0.6× 14 686
Kevin G. Shim United States 13 374 1.0× 219 0.7× 318 2.2× 25 0.2× 35 0.3× 28 634
María C. Ramello Argentina 15 494 1.3× 183 0.6× 73 0.5× 93 0.8× 28 0.2× 23 918

Countries citing papers authored by Shantan Reddy

Since Specialization
Citations

This map shows the geographic impact of Shantan Reddy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shantan Reddy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shantan Reddy more than expected).

Fields of papers citing papers by Shantan Reddy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shantan Reddy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shantan Reddy. The network helps show where Shantan Reddy may publish in the future.

Co-authorship network of co-authors of Shantan Reddy

This figure shows the co-authorship network connecting the top 25 collaborators of Shantan Reddy. A scholar is included among the top collaborators of Shantan Reddy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shantan Reddy. Shantan Reddy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Sherrill-Mix, Scott, J.K. Everett, Shantan Reddy, et al.. (2022). Multiple Introductions of SARS-CoV-2 Alpha and Delta Variants into White-Tailed Deer in Pennsylvania. mBio. 13(5). e0210122–e0210122. 34 indexed citations
2.
Ghassemi, Saba, Joseph S. Durgin, Selene Nuñez-Cruz, et al.. (2022). Rapid manufacturing of non-activated potent CAR T cells. Nature Biomedical Engineering. 6(2). 118–128. 184 indexed citations breakdown →
3.
Reddy, Shantan, et al.. (2022). Widespread, human-associated redondoviruses infect the commensal protozoan Entamoeba gingivalis. Cell Host & Microbe. 31(1). 58–68.e5. 20 indexed citations
4.
Moustafa, Ahmed M., Susan Coffin, J.K. Everett, et al.. (2021). Comparative Analysis of Emerging B.1.1.7+E484K SARS-CoV-2 Isolates. Open Forum Infectious Diseases. 8(7). ofab300–ofab300. 11 indexed citations
5.
Everett, J.K., Aoife M. Roche, Shantan Reddy, et al.. (2021). SARS-CoV-2 Genomic Variation in Space and Time in Hospitalized Patients in Philadelphia. mBio. 12(1). 12 indexed citations
6.
Nobles, Christopher L., Scott Sherrill-Mix, J.K. Everett, et al.. (2019). CD19-targeting CAR T cell immunotherapy outcomes correlate with genomic modification by vector integration. Journal of Clinical Investigation. 130(2). 673–685. 87 indexed citations
7.
Nobles, Christopher L., Shantan Reddy, January Salas-McKee, et al.. (2019). iGUIDE: an improved pipeline for analyzing CRISPR cleavage specificity. Genome biology. 20(1). 66–78. 53 indexed citations
8.
Ellebrecht, Christoph T., Eric Mukherjee, Qi Zheng, et al.. (2018). Autoreactive IgG and IgA B Cells Evolve through Distinct Subclass Switch Pathways in the Autoimmune Disease Pemphigus Vulgaris. Cell Reports. 24(9). 2370–2380. 19 indexed citations
9.
Sherman, Eric A., Christopher L. Nobles, Charles C. Berry, et al.. (2016). INSPIIRED: A Pipeline for Quantitative Analysis of Sites of New DNA Integration in Cellular Genomes. Molecular Therapy — Methods & Clinical Development. 4. 39–49. 65 indexed citations
10.
Borad, Mitesh J., Shantan Reddy, Nathan Bahary, et al.. (2014). Randomized Phase II Trial of Gemcitabine Plus TH-302 Versus Gemcitabine in Patients With Advanced Pancreatic Cancer. Journal of Clinical Oncology. 33(13). 1475–1481. 147 indexed citations
11.
Ryan, David P., Shantan Reddy, Nathan Bahary, et al.. (2013). TH-302 plus gemcitabine (G+T) versus gemcitabine (G) in patients with previously untreated advanced pancreatic cancer (PAC).. Journal of Clinical Oncology. 31(4_suppl). 325–325. 7 indexed citations
12.
Borad, Mitesh J., Shantan Reddy, Nathan Bahary, et al.. (2012). TH-302 + Gemcitabine (G + T) vs Gemcitabine (G) in Patients with Previously Untreated advanced Pancreatic Cancer (PAC). Annals of Oncology. 23. ix224–ix224. 3 indexed citations
13.
Borad, Mitesh J., Shantan Reddy, Hope E. Uronis, et al.. (2012). Abstract LB-121: Randomized phase II study of the efficacy and safety of gemcitabine + TH-302 (G+T) vs gemcitabine (G) alone in previously untreated patients with advanced pancreatic cancer. Cancer Research. 72(8_Supplement). LB–121. 8 indexed citations
14.
Ryan, David P., Shantan Reddy, Nathan Bahary, et al.. (2012). O-0008 Phase II Study of Gemcitabine + TH-302 vs Gemcitabine Alone in Patients with Locally Advanced and Metastatic Pancreatic Cancer. Annals of Oncology. 23. iv8–iv8. 1 indexed citations
15.
Fabbro, Egidio Del, Shantan Reddy, Paul Walker, & Éduardo Bruera. (2007). Palliative Sedation: When the Family and Consulting Service See No Alternative. Journal of Palliative Medicine. 10(2). 488–492. 11 indexed citations
16.
Reddy, Shantan, Éduardo Bruera, Ellen Pace, Karen Zhang, & Cielito C. Reyes‐Gibby. (2007). Clinically Important Improvement in the Intensity of Fatigue in Patients with Advanced Cancer. Journal of Palliative Medicine. 10(5). 1068–1075. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026